Short- and long-term evaluation of disease-specific symptoms and quality of life following uterine artery embolization of fibroids

Insights into Imaging

Table 3 Changes in symptom severity and HRQoL scores after UAE between short- and long-term follow-up (n = 56)

UFS-QoL subscale	n¹	Short-term follow-up Median (25. 75.P)	Long-term follow-up Median (25. 75.P)	p value (Wilcoxon test)
Symptom severity	55	18.7 (9.4 31.2)	9.4 (0.0 21.9)	0.002
Concern	54	85.0 (65.0 100.0)	100.0 (85.0 100.0)	< 0.001
Activities	55	87.5 (75.0 100.0)	100.0 (89.3 100.0)	0.002
Energy/mood	55	89.3 (78.6 100.0)	100.0 (82.1 100.0)	0.001
Control	55	90.0 (75.0 100.0)	100.0 (87.5 100.0)	0.015
Self-consciousness	55	91.7 (75.0 100.0)	100.0 (75.0 100.0)	0.391
Sexual function	50	93.7 (75.0 100.0)	100.0 (84.4 100.0)	0.265
HRQoL total score	49	87.1 (76.7 95.5)	98.3 (86.2 100.0)	0.001

(1) n = Number of patients with sufficient answered questions for the calculation of transformed scores using the ‘UFS-QoL Scoring Manual’